| PEER-REVIEWED RESEARCH |

Quantitative Rupture Testing of Soft Gelatin Capsules: Understanding Aberrant Results

This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.
/ read more /

| MANUFACTURING |

Designing Commercial-Scale Oligonucleotide Synthesis

Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
/ read more /

| ANALYTICS |

How Advanced Mass Spectrometry Technologies and Workflows are Delivering Comprehensive Protein Characterization

Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.
/ read more /

| OPERATIONS |

Best Practices in Using Isolator Technology

Consider equipment design, transfer systems, and maintenance when operating isolators for sterile manufacturing of pharmaceutical products.
/ read more /

| SUPPLY CHAIN |

Managing Risk for Cell and Gene Therapy Logistics

Vein-to-vein programmes are focusing on data access and traceability.
/ read more /

| EDITOR'S COMMENT |

Of Serious Concern?

Amid the rapidly rising cases of a novel coronavirus, concerns are being raised over preparedness and potential disruptions to the pharma supply chain.
/ read more /

| EUROPEAN REGULATORY WATCH |

Brexit: What Happens Next for Pharma?

The UK and Europe are entering a transitional period, which will involve negotiations across the board, including those on the pharma regulatory landscape.
/ read more /